A high-density lipoprotein-mediated drug delivery system.

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• High-density lipoprotein (HDL) is a dense, small lipoprotein crucial for lipid transport in plasma.
• Increasing HDL levels or function is a therapeutic target for various diseases.
• HDL particles exhibit unique physicochemical properties, including amphipathic apolipoproteins and nanoparticle characteristics.

Purpose of the Study:

• To review the structure, constituents, biogenesis, remodeling, and reconstitution of HDL drug delivery systems.
• To focus on the delivery capability, characteristics, applications, and manufacturing of HDL-based drug carriers.
• To present future prospects and challenges for HDL in pharmacodelivery.

Main Methods:

• Literature review of HDL structure and function.
• Analysis of HDL properties relevant to drug delivery.
• Examination of HDL-based drug loading, targeting, and manufacturing.

Main Results:

• HDL particles possess advantageous characteristics for drug delivery, such as biocompatibility and targeting capabilities.
• HDL drug delivery systems can be manufactured and reconstituted with specific drug-loading properties.
• HDL's heterogeneity and nanoparticle nature offer unique advantages over conventional carriers.

Conclusions:

• HDL particles represent a promising and superior platform for drug delivery applications.
• Further research into HDL biogenesis, remodeling, and reconstitution is needed for optimized drug delivery.
• Clinical translation of HDL-based pharmacodelivery systems faces challenges but holds significant future potential.